Correlation Between Baillie Gifford and Gmo Emerging

Can any of the company-specific risk be diversified away by investing in both Baillie Gifford and Gmo Emerging at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Baillie Gifford and Gmo Emerging into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Baillie Gifford Health and Gmo Emerging Country, you can compare the effects of market volatilities on Baillie Gifford and Gmo Emerging and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Baillie Gifford with a short position of Gmo Emerging. Check out your portfolio center. Please also check ongoing floating volatility patterns of Baillie Gifford and Gmo Emerging.

Diversification Opportunities for Baillie Gifford and Gmo Emerging

-0.16

Correlation Coefficient

Baillie Gifford  Gmo Emerging

Good diversification

The 3 months correlation between Baillie and Gmo is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Baillie Gifford Health and Gmo Emerging Country in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gmo Emerging Country and Baillie Gifford is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Baillie Gifford Health are associated (or correlated) with Gmo Emerging. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gmo Emerging Country has no effect on the direction of Baillie Gifford i.e., Baillie Gifford and Gmo Emerging go up and down completely randomly.

Pair Corralation between Baillie Gifford and Gmo Emerging

Assuming the 90 days horizon Baillie Gifford Health is expected to under-perform the Gmo Emerging. In addition to that, Baillie Gifford is 3.55 times more volatile than Gmo Emerging Country. It trades about -0.03 of its total potential returns per unit of risk. Gmo Emerging Country is currently generating about 0.13 per unit of volatility. If you would invest  1,557  in Gmo Emerging Country on October 24, 2024 and sell it today you would earn a total of  434.00  from holding Gmo Emerging Country or generate 27.87% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.8%
Values	Daily Returns

Baillie Gifford Health  vs.  Gmo Emerging Country

Baillie Gifford Health

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Baillie Gifford Health has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong fundamental indicators, Baillie Gifford is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Gmo Emerging Country

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Gmo Emerging Country are ranked lower than 12 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Gmo Emerging is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Baillie Gifford and Gmo Emerging

The main advantage of trading using opposite Baillie Gifford and Gmo Emerging positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Baillie Gifford position performs unexpectedly, Gmo Emerging can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gmo Emerging will offset losses from the drop in Gmo Emerging's long position.

The idea behind Baillie Gifford Health and Gmo Emerging Country pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.